Skip to Content

Adults Delaying Even Emergency Care During COVID-19

FRIDAY, Jan. 22, 2021 -- Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to the results of a survey released Jan. 12 by the Orlando Health Heart & Vascular Institute.

An online survey of 2,043 U.S. adults was conducted by The Harris Poll on behalf of the Orlando Health Heart & Vascular Institute from Dec. 4 to 7, 2020.

According to the results of the survey, 67 percent would be hesitant to attend routine, in-person appointments, while 57 percent reported being hesitant to go to the hospital even for an emergency. Nearly half (49 percent) of Americans will not reschedule missed in-person medical appointments until COVID-19 concerns are reduced in their area, and the same number (49 percent) worry their health will suffer because of in-person appointments missed due to COVID-19.

"I understand their hesitation," Steven Hoff, M.D., a cardiothoracic surgeon at the Orlando Health Heart & Vascular Institute, said in a statement. "But there's no question, across diagnoses, whether for chronic or acute conditions, the later in the disease process that we see people and can intervene, the worse their outcomes."

More Information

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

Walmart Expands COVID-19 Vaccination Program

MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...

AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants

MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...

J&J COVID-19 Vaccine Granted Emergency Use Authorization

MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.